Search by Drug Name or NDC

    NDC 43742-2085-01 HA2CG Evolution 30; 30; 8; 8; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 12; 6; 8; 8; 10 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL Details

    HA2CG Evolution 30; 30; 8; 8; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 12; 6; 8; 8; 10 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

    HA2CG Evolution is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; ECHINACEA ANGUSTIFOLIA WHOLE; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, C.

    Product Information

    NDC 43742-2085
    Product ID 43742-2085_e45af173-6f1c-48f0-929e-8c862d408935
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name HA2CG Evolution
    Proprietary Name Suffix n/a
    Non-Proprietary Name 7-Oxo-Dehydroepiandrosterone 3-Acetate, AACG-A, AACG-B, Adenosinum Triphosphoricum Dinatrum, Asclepias Vincetoxicum, Calcarea Carbonica, Cerebrum Suis, Echinacea (Angustifolia), Gambogia, Gelsemium Sempervirens, Graphites, Hepar Suis, Hypothalamus (Suis),
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 30; 30; 8; 8; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 12; 6; 8; 8; 10
    Active Ingredient Units [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
    Substance Name 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; ECHINACEA ANGUSTIFOLIA WHOLE; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, C
    Labeler Name Deseret Biologicals, Inc.
    Pharmaceutical Class Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]
    DEA Schedule n/a
    Marketing Category UNAPPROVED HOMEOPATHIC
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 43742-2085-01 (43742208501)

    NDC Package Code 43742-2085-1
    Billing NDC 43742208501
    Package 30 mL in 1 BOTTLE, DROPPER (43742-2085-1)
    Marketing Start Date 2023-05-31
    NDC Exclude Flag N
    Pricing Information N/A
    << 43742-2084-01 43742-2086-01 >>

    Contents